| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1476-5381.1985.TB09457.X |
| P8608 | Fatcat ID | release_ndblqsdhjzesxj4tsyo3tyrwi4 |
| P932 | PMC publication ID | 1916881 |
| P698 | PubMed publication ID | 3840397 |
| P5875 | ResearchGate publication ID | 19322334 |
| P2093 | author name string | Parratt JR | |
| Coker SJ | |||
| P2860 | cites work | Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides | Q28619497 |
| Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin | Q34407094 | ||
| Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds | Q34512040 | ||
| Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations. | Q34512070 | ||
| Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea | Q36128526 | ||
| Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs | Q39927748 | ||
| Studies on the characterisation of prostanoid receptors: a proposed classification | Q41533975 | ||
| Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds | Q41572758 | ||
| Experimental ischemic heart disease—Effects of synthetic thromboxane A2 | Q41622864 | ||
| Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments | Q41741296 | ||
| A comparison of methods for the measurement of cardiac output and blood oxygen content | Q44893434 | ||
| Experimental ischemic heart disease induced by thromboxane A2 in rabbits | Q44938153 | ||
| The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds. | Q51849755 | ||
| Prostacyclin—Antiarrhythmic or Arrhythmogenic? Comparison of the Effects of Intravenous and Intracoronary Prostacyclin and ZK36374 During Coronary Artery Occlusion and Reperfusion in Anaesthetised Greyhounds | Q51853183 | ||
| Some statistical methods useful in circulation research. | Q52759617 | ||
| Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias | Q59060568 | ||
| Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine | Q69382893 | ||
| Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes | Q70433614 | ||
| Nifedipine Reduces Arrhythmias But Does Not Alter Prostanoid Release During Coronary Artery Occlusion and Reperfusion in Anaesthetised Greyhounds | Q72702413 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 259-264 | |
| P577 | publication date | 1985-09-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds | |
| P478 | volume | 86 |
| Q24630260 | 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation |
| Q73879615 | 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat |
| Q35041812 | Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury |
| Q38020347 | Cardiovascular effects of omega-3 polyunsaturated fatty acids (fish oils). |
| Q77950881 | Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats |
| Q68497948 | Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion |
| Q46903554 | Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts |
| Q42978567 | Effect of the specific thromboxane receptor blocking drug AH23848 in patients with angina pectoris |
| Q42715382 | Effects of cicletanine on haemodynamics, arrhythmias and extent of necrosis during coronary ligation in rabbits |
| Q37236040 | Estrogen-mediated protection in myocardial ischemia-reperfusion injury |
| Q33561234 | Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway. |
| Q39612952 | Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactions |
| Q34397736 | Pharmacokinetics of the thromboxane A2 receptor antagonist sulotroban (BM 13.177) in renal failure |
| Q41290150 | Platelet activation during myocardial ischaemia: a contributory arrhythmogenic mechanism |
| Q73113078 | Protective actions of a thromboxane receptor antagonist, SQ 29548 on the ischemic myocardium: morphologic and hemodynamic effects |
| Q47391649 | Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury |
| Q42705527 | Suppression of reperfusion-induced arrhythmias with combined administration of 5-HT2 and thromboxane A2 antagonists |
| Q38037986 | The potential role of thromboxane inhibitors in preventing myocardial ischaemic injury |
| Q71568584 | Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction |
| Q37113049 | Thromboxane A2 receptor antagonists |
| Q46844250 | Thromboxane A2-induced arrhythmias in the anesthetized rabbit |
Search more.